APAC IPOs & Placements

Zhen Zhou, Toh

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Guangdong Kanghua Healthcare / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/22933" target="_blank" data-smartkarma-citation="entities:22933:1">Guangdong Kanghua Healthcare (3689 HK)</a> plans to raise about US$126 - 157m in its IPO through selling 84m primary share. Our fellow insight provider, <a href="https://www.smartkarma.com/profiles/803" target="_blank" data-smartkarma-citation="accounts:803">Valerie Law</a>, has covered GDKH in her insights: <a href="https://www.smartkarma.com/insights/ipo-preview-guangdong-kanghua-s-near-term-margin-headwinds" target="_blank" data-smartkarma-citation="insights:5639">IPO Preview: Guangdong Kanghua’s Near-Term Margin Headwinds</a> and <a href="https://www.smartkarma.com/insights/guangdong-kanghua-ipo-concentration-risk-and-more-track-record-needed" target="_blank" data-smartkarma-citation="insights:5215">Guangdong Kanghua IPO: Concentration Risk and More Track Record Needed</a>. In this insight, we look to build upon her analysis and look at GDKH's operational data for both Renkang and Kanghua Hospitals, comparison to the group to other hospitals and examine its valuation with other listed peers. We will also run the deal through our ECM framework.

 Guangdong Kanghua Healthcare (3689 HK) plans to raise about US$126 - 157m in its IPO through selling 84m primary share. Our fellow insight provider, Valerie Law, has covered GDKH in her insights: IPO Preview: Guangdong Kanghua’s Near-Term Margin Headwinds and Guangdong Kanghua IPO: Concentration Risk and More Track Record Needed. In this insight, we look to build upon her analysis and look at GDKH's operational data for both Renkang and Kanghua Hospitals, comparison to the group to other hospitals and examine its valuation with other listed peers. We will also run the deal through our ECM framework.

Guangdong Kanghua IPO Review - Two Average Hospitals Not Deserving of a Premium